Sign In to Follow Application
View All Documents & Correspondence

Hair Care Composition Comprising A Dendritic Macromolecule

Abstract: Hair care composition comprising an emulsified hydrophobically functionalised dendritic macromolecule.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
03 June 2011
Publication Number
01/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2017-07-28
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
HINDUSTAN LVER HOUSE, 165-166 BACKBAY RECLAMATION, MUMBAI, 400 020, INDIA

Inventors

1. DERICI LEO
UNILEVER R & D PORT SUNLIGHT, QUARRY ROAD EAST, BEBINGTON, WIRRAL, MERSEYSIDE, CH63 3JW, UNITED KINGDOM
2. HARCUP JASON PETER
CONOPCO, INC.D/B/A UNILEVER, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, UNITED STATES OF AMERICA
3. HILL STUART PAUL
UNILEVER R & D PORT SUNLIGHT, QUARRY ROAD EAST, BEBINGTON, WIRRAL, MERSEYSIDE, CH63 3JW, UNITED KINGDOM
4. KHOSHDEL EZAT
UNILEVER R & D PORT SUNLIGHT,QUARRY ROAD EAST,BEBINGTON,WIRRAL, MERSEYSIDE,CH63 3JW,UNITED KINGDOM

Specification

FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
HAIR CARE COMPOSITION COMPRISING A DENDRITIC MACROMOLECULE
HINDUSTAN UNILEVER LIMITED, a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed

HAIR CARE COMPOSITION COMPRISING A DENDRITIC MACROMOLECULE
The present invention relates to a hair care composition comprising non-linear polymers.
US 2007/202071 discloses compositions comprising dendritic molecules as emulsifying agents. However, by their physical nature such dendritic molecules are not capable of delivering the benefits of the invention.
In addition, whereas dendritic macromolecules decreasing the volume of hair have been disclosed before in hair care compositions, the invention shows that compositions in which the hydrophobically modified dendritic macromolecule is emulsified prior to incorporation into the composition have even lower volume compared to those compositions with dendritic macromolecules that are not emulsified.
Accordingly, the present invention relates to a hair care composition according to claim 1.
Dendritic macromolecules are macromolecules with densely branched structures having a large number of end groups. A dendritic polymer includes several layers or generations of repeating units which all contain one or more branch points. Dendritic polymers, including dendrimers and hyperbranched polymers, are prepared by condensation reactions of monomeric units having at least two different types of reactive groups. Dendrimers are highly symmetric, whereas macromolecules designated as hyperbranched may to a certain degree hold an asymmetry, yet maintaining the highly branched treelike structure.
Dendritic macromolecules normally consist of an initiator or nucleus having one or more reactive sites and a number of branching layers and optionaliy a layer of

chain terminating molecules. Continued replication of branching layers normally yields increased branch multiplicity and, where applicable or desired, increased number of terminal groups. The layers are usually called generations and the branches dendrons.
In a preferred embodiment the dendritic macromolecule to be hydrophobically modified is a hydroxyl-functionalised dendritic macromolecule and more preferably one which comprises polyester units.
Suitable materials are described in SE 468 771, which discloses a macromolecule which is composed of an initiator, having at least one hydroxyl group, to which initiator is added at least one branching generation comprising at least one chain extender, having at least one carboxyl group and at least two hydroxyl groups.
Further suitable materials are described in SE 503 342, in which the macromolecule is substantially composed of a nucleus, having at least one epoxide group, to which nucleus is added at least one branching generation comprising at least one chain extender, having at least three reactive functions of which at least one is a carboxyl or epoxide group and at least one is a hydroxyl group.
These materials are also referred to as polyhydric polyester alcohols or hyperbranched polyols. Preferably these materials have at least eight, more preferably at least sixteen, most preferably at least thirty-two terminal hydroxyl groupings per macromolecule. Their molecular weight is preferably at least 800, more preferably at least 1600, most preferably at least 2500 g/mole.
These materials are available commercially from Perstorp AB, SE-284 80 Perstorp, Sweden under the trademark of BOLTORN. Examples of such materials

are BOLTORN H10, BOLTORN H20, BOLTORN H30 and BOLTORN H40, of which BOLTORN H30 and BOLTORN H40 are preferred.
It is preferred if the generation number of the polymer is 2 or greater. The maximum generation number is preferably 9 or less, more preferably 7 or less.
Preferred hydrophobically functionalised dendritic macromoiecules are built up from polyester units. Suitable macromoiecules of this type are disclosed in US 5 418 301 and can be sold under the tradename Perstop.
Other preferred dendritic macromoiecules are built up from polyamide units. Suitable macromoiecules of this type are disclosed in Macromoiecules 2001, 34, 3559-3566 and are sold under the tradename Hybrane. Preferably the groups are selected from succinic anhydride units, dodecyl succinic anhydride units, hexahydrophthalic anhydride units and phthalic anhydride units or mixtures thereof.
The level of hydrophobically functionalised dendritic macromolecule is preferably from 0.0001 to 30 wt% of the total composition, more preferably the level is from 0.05 to 8 wt%, most preferably from 0.1 to 5 wt%.
Preferably the number average molecular weight of the polymers are from 500 to 50,000, more preferably the number average molecular weight to from 500 to 10,000; most preferably the number average molecular weight is from 750 to 5,000.
Preferably, the dendritic macromolecule comprises polyester, polyether, polyamide, polyanhydride units or mixtures thereof.

In a particular embodiment the dendritic macromolecule comprises units selected from succinic anhydride units, dodecyl succinic anhydride units, hexahydrophthalic anhydride units and phthalic anhydride units or mixtures thereof.
Hydrophobic modification
Preferred hydrophobic groups are carbon based. C4-C24 alkyl or aikenyl groups are preferred hydrophobic groups, more preferred are C6-C22 alkyl or alkenyl groups, especially preferred are C8-C16 alkyl or aikenyl groups, most preferred are dendritic macromolecule having C10-C14 alkyl or aikenyl groups. The hydrophobic groups may include linear and branched hydrophobes as well as arylalkyl groups, however it is preferred if the alkyl hydrophobic groups are linear. The hydrophobic groups may be unsaturated groups but are preferably saturated. The hydrophobic groups are sometimes linked to the dendritic macromolecule through linking groups, suitable linking groups include ester or amide groups.
In some instances it is preferred if the dendritic macromolecule is fully or partially hydrophobically functionalised at the periphery and/or the terminal groups of the dendritic macromolecule. (In the context of the present invention the term periphery means the outer layer or edge of the dendritic macromolecule.)
Where the dendritic macromolecule is hydrophobically functionalised at the periphery preferably 5 to 95% of the terminal groups are hydrophobically functionalised, more preferably from 10 to 85%, most preferably from 20 to 60%.
In a further embodiment the number of hydrophobic groups can be expressed as a percentage of the potential sites on the dendritic macromolecule available for hydrophobic modification both on the periphery of the molecule and internally within the molecule. Preferably 10 to 90 % of these available sites are

hydrophobically modified, more preferably 20 to 70% are hydrophobically modified.
Hydrophobic modification is a simple process of reacting with the relevant fatty acid, fatty ester or fatty anhydride.
Examples of hydrophobically modified dendritic polymers include those commercially available as Boltorn H2004 and Boltorn W3000.
Preferably the composition is a shampoo composition and comprises materials commonly found in shampoo compositions such as silicones; cleansing surfactants such as anionic surfactants, amphoteric surfactants, nonionic surfactants and mixtures thereof.
Preferably, the composition according to the invention is a conditioning composition. Conditioning compositions according to the invention will comprise conditioning surfactants and actives such as silicones, fatty materials selected from alcohols, acids, amides and mixtures thereof.
Preferably, the composition according to the invention is a rinse-off composition.
Preparation of the dendritic macromolecule emulsion for incorporation into a formulation as described in Example 1
Table 1 -Example 1

Ingredient Active % wt.
Boltorn H2004 20.00
Cetyl trimethylammonium chloride (CTAC) 3.00
Pluracare F77 3.00
Water To 100.00

Water and CTAC were added to a beaker and heated to 60 °c until dissolved. Pluracare F77 was added while maintaining temperature at 60 °c, stirring with a spatula until dissolved. The mixture was allowed to cool and then transferred to a Silverson high shear rotor/stator laboratory mixer on speed 1 to which Boltorn H2004 was slowly added. The speed was increased to 6 and mixed for a further 20 minutes.
The following examples are shampoo compositions according to the invention to which Boltorn H2004 and emulsified Boltorn H2004 were added.
Table 2 - Shampoo Compositions

Ingredient Active % wt.
A B
Examples 2 3 4 5 2 3 4 5
Sodium laureth (1EO) sulphate (SLES 1EO) 12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00
Coco amidopropyl betaine (CAPB) 1.60 1.60 1.60 1.60 1.60 1.60 1.60 1.60
Guarhydroxypropyl trimonium chloride 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Silicone emulsion 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Boltorn H2004 0.10 0.50 1.0 2.0 - - - -
Emulsified Boltorn H2004 (Example 1) 0.10 0.50 1.0 2.0
Sodium chloride q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s.
Water and minors To 100 To 100 To 100 To 100 To 100 To 100 To 100 To 100

The following examples are conditioner compositions according to the invention to which Bottom H2004 and emulsified Boltorn H2004 were added.
Table 3 - Conditioner Compositions

Ingredient Active % wt.
A B
Examples 6 7 6 7
Lactic acid 0.38 0.38 0.38 0.38
Stearamidopropyl dimethyl amine 1.25 1.25 1.25 1.25
Behentrimonium chloride 0.87 0.87 0.87 0.87
Cetearyl alcohol (30/70 C16/18) 5.00 5.00 5.00 5.00
Silicone emulsion 2.50 2.50 2.50 2.50
Boltorn H2004 2.00 4.00 - -
Emulsified Boltorn H2004 (Example 1) - - 2.00 4.00
Water and minors To 100 To 100 To 100 To 100
Table 4 - Silhouette volume results for shampoo compositions with Boltorn H2004 and emulsified Boltorn H2004

Example Silhouette volume / mm2
A B
2 7520 6114
3 7742 6397
4 7763 6490
5 5461 3477
Example 2 - 0.10% Boltorn H2004 Example 3 - 0.50% Boltorn H2004

Example 4 - 1.00% Boltorn H2004 Example 5 - 2.00% Boltorn H2004
A Boltorn H2004
B Emulsified Boltorn H2004
The table shows that shampoo compositions with emulsified Boltorn H2004 provide a lower volume than those compositions with Boltorn H2004. The experiment was carried out on uncombed hair.
Table 5 - Silhouette volume results for conditioner compositions with Boltorn H2004 and emulsified Boltorn H2004

Example Silhouette volume / mm2
A B
6 5049 3984
7 4115 3651
Example 6 - 2.00% Boltorn H2004 Example 7 - 4.00% Boltorn H2004
A Boltorn H2004
B Emulsified Boltorn H2004
The table shows that conditioner compositions with emulsified Boltorn H2004 provide a lower volume than those compositions with Boltorn H2004. The experiment was carried out on uncombed hair.

CLAIMS
1. Hair care composition comprising an emulsified hydrophobically functionalrsed dendritic macromolecure which is emulsified prior to incorporation into the composition.
2. Composition according to any preceding claim wherein the dendritic macromolecule is a hydrophobically functionalrsed dendritic macromolecule.
3. Composition according to any preceding claim wherein the dendritic macromolecule is hydroxyl-modified.
4. Composition according to claim 1 or 2 in which the hydrophobically functionalised group of the dendritic macromolecule comprises a C4-C24 alkyl or alkenyl group.
5. Composition according to claim 1 or 2 wherein the hydrophobic functronalised group comprises a C10-14 carboxyl group.
6. Composition according to any preceding claim wherein the dendritic macromolecule comprises polyester, polyether, polyamide, polyanhydride units or mixtures thereof.
7. Composition according to any preceding claim wherein the dendritic macromolecule comprises units selected from succinic anhydride units, dodecyl succinic anhydride units, hexahydrophthalic anhydride units and phthalic anhydride units or mixtures thereof.

8. Cosmetic and personal care composition according to any preceding claim in which the hydrophobicaiiy functionalised groups of the dendritic macromofecule are situated at the terminals of the macromolecule.
9. Composition according to any preceding claim in which the level of hydrophobicaiiy functionalised dendritic rnacromolecule is from 0.0001 to 30 wt% of the total composition.
10. Composition according to any preceding claim which is a shampoo composition.
11. Composition according to any preceding claim which is a conditioning composition.
12. Composition according to any preceding claim which is a rinse-off composition.

Documents

Application Documents

# Name Date
1 1136-MUMNP-2011-FORM 3(10-12-2013).pdf 2013-12-10
1 1136-MUMNP-2011-FORM-27 [28-08-2024(online)].pdf 2024-08-28
2 1136-MUMNP-2011-FORM 3(10-11-2014).pdf 2014-11-10
2 1136-MUMNP-2011-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
3 1136-MUMNP-2011-FORM 3-(25-04-2015).pdf 2015-04-25
3 1136-MUMNP-2011-RELEVANT DOCUMENTS [14-09-2022(online)].pdf 2022-09-14
4 1136-MUMNP-2011-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
4 1136-MUMNP-2011-FORM PCT-ISA-210-(14-03-2016).pdf 2016-03-14
5 1136-mumnp-2011-claims.doc 2018-08-10
5 1136-MUMNP-2011-EP DOCUMENT-(14-03-2016).pdf 2016-03-14
6 1136-MUMNP-2011-CORRESPONDENCE-(14-03-2016).pdf 2016-03-14
6 1136-MUMNP-2011-CLAIMS.pdf 2018-08-10
7 1136-MUMNP-2011-CORRESPONDENCE(10-9-2012).pdf 2018-08-10
7 Other Document [07-10-2016(online)].pdf_163.pdf 2016-10-07
8 1136-MUMNP-2011-CORRESPONDENCE(9-8-2011).pdf 2018-08-10
8 Other Document [07-10-2016(online)].pdf_159.pdf 2016-10-07
9 1136-mumnp-2011-correspondence.pdf 2018-08-10
9 Other Document [07-10-2016(online)].pdf_156.pdf 2016-10-07
10 Other Document [07-10-2016(online)].pdf 2016-10-07
10 1136-mumnp-2011-description(complete).pdf 2018-08-10
11 Examination Report Reply Recieved [07-10-2016(online)].pdf_162.pdf 2016-10-07
11 1136-mumnp-2011-form 1.pdf 2018-08-10
12 Examination Report Reply Recieved [07-10-2016(online)].pdf_161.pdf 2016-10-07
12 1136-MUMNP-2011-FORM 13(14-2-2012).pdf 2018-08-10
13 1136-MUMNP-2011-FORM 18(10-9-2012).pdf 2018-08-10
13 Examination Report Reply Recieved [07-10-2016(online)].pdf_157.pdf 2016-10-07
14 1136-mumnp-2011-form 2(title page).pdf 2018-08-10
14 Examination Report Reply Recieved [07-10-2016(online)].pdf 2016-10-07
15 Description(Complete) [07-10-2016(online)].pdf_164.pdf 2016-10-07
16 Description(Complete) [07-10-2016(online)].pdf_160.pdf 2016-10-07
16 1136-mumnp-2011-form 2.pdf 2018-08-10
17 Description(Complete) [07-10-2016(online)].pdf_158.pdf 2016-10-07
17 1136-MUMNP-2011-FORM 3(12-8-2011).pdf 2018-08-10
18 Description(Complete) [07-10-2016(online)].pdf 2016-10-07
18 1136-MUMNP-2011-FORM 3(15-2-2012).pdf 2018-08-10
19 Claims [07-10-2016(online)].pdf 2016-10-07
19 1136-MUMNP-2011-FORM 3(21-5-2014).pdf 2018-08-10
20 1136-MUMNP-2011-FORM 3(22-6-2013).pdf 2018-08-10
20 1136-MUMNP-2011-HARD COPY OF FER-18-10-2016.pdf 2016-10-18
21 1136-MUMNP-2011-FORM 3(23-1-2013).pdf 2018-08-10
21 1136-MUMNP-2011-ASSIGNMENT-18-10-2016.pdf 2016-10-18
22 1136-MUMNP-2011-FORM 3(8-8-2012).pdf 2018-08-10
22 Other Document [22-05-2017(online)].pdf 2017-05-22
23 1136-MUMNP-2011-Form 3-081015.pdf 2018-08-10
23 Form 26 [22-05-2017(online)].pdf 2017-05-22
24 1136-MUMNP-2011-Form 3-120816.pdf 2018-08-10
24 Form 13 [22-05-2017(online)].pdf 2017-05-22
25 1136-MUMNP-2011-Form 3-190316.pdf 2018-08-10
25 HEARING ADJOURNMENT [29-05-2017(online)].pdf 2017-05-29
26 1136-mumnp-2011-form 3.pdf 2018-08-10
26 1136-MUMNP-2011-ORIGINAL UNDER RULE 6 (1A)-30-05-2017.pdf 2017-05-30
27 1136-mumnp-2011-form 5.pdf 2018-08-10
27 Correspondence to notify the Controller [12-07-2017(online)].pdf 2017-07-12
28 1136-mumnp-2011-form pct-ipea-409.pdf 2018-08-10
28 1136-MUMNP-2011-FORM 3-18-07-2017.pdf 2017-07-18
29 1136-mumnp-2011-form pct-isa-210.pdf 2018-08-10
29 1136-mumnp-2011-Written submissions and relevant documents (MANDATORY) [27-07-2017(online)].pdf 2017-07-27
30 1136-MUMNP-2011-GENERAL POWER OF ATTORNEY(9-8-2011).pdf 2018-08-10
30 1136-MUMNP-2011-PETITION UNDER RULE 137 [27-07-2017(online)].pdf 2017-07-27
31 1136-MUMNP-2011-HearingNoticeLetter.pdf 2018-08-10
31 1136-MUMNP-2011-PatentCertificate28-07-2017.pdf 2017-07-28
32 1136-MUMNP-2011-Original Under Rule 6(1 A)Form 3-250117.pdf 2018-08-10
32 OTHERS 4.pdf_59.pdf 2018-08-10
33 1136-mumnp-2011-other document.pdf 2018-08-10
33 OTHERS 4.pdf_46.pdf 2018-08-10
34 1136-mumnp-2011-other pct document.pdf 2018-08-10
34 OTHERS 4.pdf_33.pdf 2018-08-10
35 1136-MUMNP-2011-PatentCertificateCoverLetter.pdf 2018-08-10
35 OTHERS 4.pdf 2018-08-10
36 1136-mumnp-2011-wo international publication report a1.pdf 2018-08-10
36 OTHERS 3.pdf_57.pdf 2018-08-10
37 1136-MUMNP-2011_EXAMREPORT.pdf 2018-08-10
37 OTHERS 3.pdf_44.pdf 2018-08-10
38 Amended claims (marked up and clean copies).pdf 2018-08-10
38 OTHERS 3.pdf_31.pdf 2018-08-10
39 OTHERS 3.pdf 2018-08-10
39 Amended claims (marked up and clean copies).pdf_24.pdf 2018-08-10
40 Amended claims (marked up and clean copies).pdf_37.pdf 2018-08-10
40 OTHERS 2.pdf_53.pdf 2018-08-10
41 Amended claims (marked up and clean copies).pdf_50.pdf 2018-08-10
41 OTHERS 2.pdf_40.pdf 2018-08-10
42 FER RESPONSE_PCC6406.pdf 2018-08-10
42 OTHERS 2.pdf_27.pdf 2018-08-10
43 FER RESPONSE_PCC6406.pdf_18.pdf 2018-08-10
43 OTHERS 2.pdf 2018-08-10
44 FER RESPONSE_PCC6406.pdf_19.pdf 2018-08-10
44 OTHERS 1.pdf_52.pdf 2018-08-10
45 FER RESPONSE_PCC6406.pdf_21.pdf 2018-08-10
45 OTHERS 1.pdf_39.pdf 2018-08-10
46 OTHERS 1.pdf_26.pdf 2018-08-10
46 FER RESPONSE_PCC6406.pdf_23.pdf 2018-08-10
47 OTHERS 1.pdf 2018-08-10
47 FER RESPONSE_PCC6406.pdf_29.pdf 2018-08-10
48 Originally filed FORM 2-title page.pdf_61.pdf 2018-08-10
48 FER RESPONSE_PCC6406.pdf_30.pdf 2018-08-10
49 Originally filed FORM 2-title page.pdf_58.pdf 2018-08-10
49 FER RESPONSE_PCC6406.pdf_34.pdf 2018-08-10
50 Originally filed FORM 2-title page.pdf_54.pdf 2018-08-10
50 FER RESPONSE_PCC6406.pdf_36.pdf 2018-08-10
51 FER RESPONSE_PCC6406.pdf_42.pdf 2018-08-10
51 Originally filed FORM 2-title page.pdf_51.pdf 2018-08-10
52 Originally filed FORM 2-title page.pdf_48.pdf 2018-08-10
52 FER RESPONSE_PCC6406.pdf_43.pdf 2018-08-10
53 FER RESPONSE_PCC6406.pdf_47.pdf 2018-08-10
53 Originally filed FORM 2-title page.pdf_45.pdf 2018-08-10
54 FER RESPONSE_PCC6406.pdf_49.pdf 2018-08-10
54 Originally filed FORM 2-title page.pdf_41.pdf 2018-08-10
55 FER RESPONSE_PCC6406.pdf_55.pdf 2018-08-10
55 Originally filed FORM 2-title page.pdf_38.pdf 2018-08-10
56 FER RESPONSE_PCC6406.pdf_56.pdf 2018-08-10
56 Originally filed FORM 2-title page.pdf_35.pdf 2018-08-10
57 FER RESPONSE_PCC6406.pdf_60.pdf 2018-08-10
57 Originally filed FORM 2-title page.pdf_32.pdf 2018-08-10
58 Originally filed FORM 2-title page.pdf 2018-08-10
58 Originally filed FORM 2-title page.pdf_28.pdf 2018-08-10
59 Originally filed FORM 2-title page.pdf_17.pdf 2018-08-10
59 Originally filed FORM 2-title page.pdf_25.pdf 2018-08-10
60 Originally filed FORM 2-title page.pdf_22.pdf 2018-08-10
60 Originally filed FORM 2-title page.pdf_20.pdf 2018-08-10
61 Originally filed FORM 2-title page.pdf_20.pdf 2018-08-10
61 Originally filed FORM 2-title page.pdf_22.pdf 2018-08-10
62 Originally filed FORM 2-title page.pdf_17.pdf 2018-08-10
62 Originally filed FORM 2-title page.pdf_25.pdf 2018-08-10
63 Originally filed FORM 2-title page.pdf 2018-08-10
63 Originally filed FORM 2-title page.pdf_28.pdf 2018-08-10
64 FER RESPONSE_PCC6406.pdf_60.pdf 2018-08-10
64 Originally filed FORM 2-title page.pdf_32.pdf 2018-08-10
65 Originally filed FORM 2-title page.pdf_35.pdf 2018-08-10
65 FER RESPONSE_PCC6406.pdf_56.pdf 2018-08-10
66 FER RESPONSE_PCC6406.pdf_55.pdf 2018-08-10
66 Originally filed FORM 2-title page.pdf_38.pdf 2018-08-10
67 FER RESPONSE_PCC6406.pdf_49.pdf 2018-08-10
67 Originally filed FORM 2-title page.pdf_41.pdf 2018-08-10
68 FER RESPONSE_PCC6406.pdf_47.pdf 2018-08-10
68 Originally filed FORM 2-title page.pdf_45.pdf 2018-08-10
69 FER RESPONSE_PCC6406.pdf_43.pdf 2018-08-10
69 Originally filed FORM 2-title page.pdf_48.pdf 2018-08-10
70 FER RESPONSE_PCC6406.pdf_42.pdf 2018-08-10
70 Originally filed FORM 2-title page.pdf_51.pdf 2018-08-10
71 FER RESPONSE_PCC6406.pdf_36.pdf 2018-08-10
71 Originally filed FORM 2-title page.pdf_54.pdf 2018-08-10
72 FER RESPONSE_PCC6406.pdf_34.pdf 2018-08-10
72 Originally filed FORM 2-title page.pdf_58.pdf 2018-08-10
73 FER RESPONSE_PCC6406.pdf_30.pdf 2018-08-10
73 Originally filed FORM 2-title page.pdf_61.pdf 2018-08-10
74 OTHERS 1.pdf 2018-08-10
74 FER RESPONSE_PCC6406.pdf_29.pdf 2018-08-10
75 FER RESPONSE_PCC6406.pdf_23.pdf 2018-08-10
75 OTHERS 1.pdf_26.pdf 2018-08-10
76 FER RESPONSE_PCC6406.pdf_21.pdf 2018-08-10
76 OTHERS 1.pdf_39.pdf 2018-08-10
77 FER RESPONSE_PCC6406.pdf_19.pdf 2018-08-10
77 OTHERS 1.pdf_52.pdf 2018-08-10
78 FER RESPONSE_PCC6406.pdf_18.pdf 2018-08-10
78 OTHERS 2.pdf 2018-08-10
79 FER RESPONSE_PCC6406.pdf 2018-08-10
79 OTHERS 2.pdf_27.pdf 2018-08-10
80 Amended claims (marked up and clean copies).pdf_50.pdf 2018-08-10
80 OTHERS 2.pdf_40.pdf 2018-08-10
81 OTHERS 2.pdf_53.pdf 2018-08-10
81 Amended claims (marked up and clean copies).pdf_37.pdf 2018-08-10
82 Amended claims (marked up and clean copies).pdf_24.pdf 2018-08-10
82 OTHERS 3.pdf 2018-08-10
83 Amended claims (marked up and clean copies).pdf 2018-08-10
83 OTHERS 3.pdf_31.pdf 2018-08-10
84 OTHERS 3.pdf_44.pdf 2018-08-10
84 1136-MUMNP-2011_EXAMREPORT.pdf 2018-08-10
85 1136-mumnp-2011-wo international publication report a1.pdf 2018-08-10
85 OTHERS 3.pdf_57.pdf 2018-08-10
86 1136-MUMNP-2011-PatentCertificateCoverLetter.pdf 2018-08-10
86 OTHERS 4.pdf 2018-08-10
87 1136-mumnp-2011-other pct document.pdf 2018-08-10
87 OTHERS 4.pdf_33.pdf 2018-08-10
88 1136-mumnp-2011-other document.pdf 2018-08-10
88 OTHERS 4.pdf_46.pdf 2018-08-10
89 1136-MUMNP-2011-Original Under Rule 6(1 A)Form 3-250117.pdf 2018-08-10
89 OTHERS 4.pdf_59.pdf 2018-08-10
90 1136-MUMNP-2011-HearingNoticeLetter.pdf 2018-08-10
90 1136-MUMNP-2011-PatentCertificate28-07-2017.pdf 2017-07-28
91 1136-MUMNP-2011-PETITION UNDER RULE 137 [27-07-2017(online)].pdf 2017-07-27
91 1136-MUMNP-2011-GENERAL POWER OF ATTORNEY(9-8-2011).pdf 2018-08-10
92 1136-mumnp-2011-form pct-isa-210.pdf 2018-08-10
92 1136-mumnp-2011-Written submissions and relevant documents (MANDATORY) [27-07-2017(online)].pdf 2017-07-27
93 1136-MUMNP-2011-FORM 3-18-07-2017.pdf 2017-07-18
93 1136-mumnp-2011-form pct-ipea-409.pdf 2018-08-10
94 1136-mumnp-2011-form 5.pdf 2018-08-10
94 Correspondence to notify the Controller [12-07-2017(online)].pdf 2017-07-12
95 1136-mumnp-2011-form 3.pdf 2018-08-10
95 1136-MUMNP-2011-ORIGINAL UNDER RULE 6 (1A)-30-05-2017.pdf 2017-05-30
96 HEARING ADJOURNMENT [29-05-2017(online)].pdf 2017-05-29
96 1136-MUMNP-2011-Form 3-190316.pdf 2018-08-10
97 1136-MUMNP-2011-Form 3-120816.pdf 2018-08-10
97 Form 13 [22-05-2017(online)].pdf 2017-05-22
98 1136-MUMNP-2011-Form 3-081015.pdf 2018-08-10
98 Form 26 [22-05-2017(online)].pdf 2017-05-22
99 1136-MUMNP-2011-FORM 3(8-8-2012).pdf 2018-08-10
99 Other Document [22-05-2017(online)].pdf 2017-05-22
100 1136-MUMNP-2011-ASSIGNMENT-18-10-2016.pdf 2016-10-18
100 1136-MUMNP-2011-FORM 3(23-1-2013).pdf 2018-08-10
101 1136-MUMNP-2011-FORM 3(22-6-2013).pdf 2018-08-10
101 1136-MUMNP-2011-HARD COPY OF FER-18-10-2016.pdf 2016-10-18
102 1136-MUMNP-2011-FORM 3(21-5-2014).pdf 2018-08-10
102 Claims [07-10-2016(online)].pdf 2016-10-07
103 1136-MUMNP-2011-FORM 3(15-2-2012).pdf 2018-08-10
103 Description(Complete) [07-10-2016(online)].pdf 2016-10-07
104 1136-MUMNP-2011-FORM 3(12-8-2011).pdf 2018-08-10
104 Description(Complete) [07-10-2016(online)].pdf_158.pdf 2016-10-07
105 1136-mumnp-2011-form 2.pdf 2018-08-10
105 Description(Complete) [07-10-2016(online)].pdf_160.pdf 2016-10-07
106 Description(Complete) [07-10-2016(online)].pdf_164.pdf 2016-10-07
107 Examination Report Reply Recieved [07-10-2016(online)].pdf 2016-10-07
107 1136-mumnp-2011-form 2(title page).pdf 2018-08-10
108 1136-MUMNP-2011-FORM 18(10-9-2012).pdf 2018-08-10
108 Examination Report Reply Recieved [07-10-2016(online)].pdf_157.pdf 2016-10-07
109 1136-MUMNP-2011-FORM 13(14-2-2012).pdf 2018-08-10
109 Examination Report Reply Recieved [07-10-2016(online)].pdf_161.pdf 2016-10-07
110 Examination Report Reply Recieved [07-10-2016(online)].pdf_162.pdf 2016-10-07
110 1136-mumnp-2011-form 1.pdf 2018-08-10
111 1136-mumnp-2011-description(complete).pdf 2018-08-10
111 Other Document [07-10-2016(online)].pdf 2016-10-07
112 1136-mumnp-2011-correspondence.pdf 2018-08-10
112 Other Document [07-10-2016(online)].pdf_156.pdf 2016-10-07
113 1136-MUMNP-2011-CORRESPONDENCE(9-8-2011).pdf 2018-08-10
113 Other Document [07-10-2016(online)].pdf_159.pdf 2016-10-07
114 1136-MUMNP-2011-CORRESPONDENCE(10-9-2012).pdf 2018-08-10
114 Other Document [07-10-2016(online)].pdf_163.pdf 2016-10-07
115 1136-MUMNP-2011-CORRESPONDENCE-(14-03-2016).pdf 2016-03-14
115 1136-MUMNP-2011-CLAIMS.pdf 2018-08-10
116 1136-MUMNP-2011-EP DOCUMENT-(14-03-2016).pdf 2016-03-14
117 1136-MUMNP-2011-FORM PCT-ISA-210-(14-03-2016).pdf 2016-03-14
117 1136-MUMNP-2011-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
118 1136-MUMNP-2011-FORM 3-(25-04-2015).pdf 2015-04-25
118 1136-MUMNP-2011-RELEVANT DOCUMENTS [14-09-2022(online)].pdf 2022-09-14
119 1136-MUMNP-2011-FORM 3(10-11-2014).pdf 2014-11-10
119 1136-MUMNP-2011-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
120 1136-MUMNP-2011-FORM-27 [28-08-2024(online)].pdf 2024-08-28

ERegister / Renewals

3rd: 31 Jul 2017

From 02/12/2011 - To 02/12/2012

4th: 31 Jul 2017

From 02/12/2012 - To 02/12/2013

5th: 31 Jul 2017

From 02/12/2013 - To 02/12/2014

6th: 31 Jul 2017

From 02/12/2014 - To 02/12/2015

7th: 31 Jul 2017

From 02/12/2015 - To 02/12/2016

8th: 31 Jul 2017

From 02/12/2016 - To 02/12/2017

9th: 31 Jul 2017

From 02/12/2017 - To 02/12/2018

10th: 22 Nov 2018

From 02/12/2018 - To 02/12/2019

11th: 08 Nov 2019

From 02/12/2019 - To 02/12/2020

12th: 30 Nov 2020

From 02/12/2020 - To 02/12/2021

13th: 03 Dec 2021

From 02/12/2021 - To 02/12/2022

14th: 02 Dec 2022

From 02/12/2022 - To 02/12/2023

15th: 04 Nov 2023

From 02/12/2023 - To 02/12/2024

16th: 26 Nov 2024

From 02/12/2024 - To 02/12/2025